Sunday, 25 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Deals
Stada Arzneimittel AG Partners with CR Sanjiu for Distribution in China
January 31, 2025
Company
Drug
C2 Pharma Secures C-DMF Approval for Pilocarpine Nitrate API
November 4, 2024
Company
Drug
SCG Cell Therapy’s SCG101 Receives Tacit Approval for Cholangiocarcinoma Clinical Trial in China
November 4, 2024
Company
Drug
Akeso Biopharma’s Cadonilimab Meets Primary Endpoint in Phase III Cervical Cancer Study
November 4, 2024
Company
Drug
RemeGen’s Telitacicept Receives Full Approval for Systemic Lupus Erythematosus in China
November 4, 2024
Company
Deals
Boehringer Ingelheim Acquires T3 Pharmaceuticals to Boost Immuno-Oncology Portfolio
November 4, 2024
Company
Drug
Bayer Halts Late-Stage Trial for Asundexian After Underperformance
November 4, 2024
Company
Drug
Brii Biosciences’ BRII-179 Vaccine on Track for Breakthrough Therapy Designation in China
November 4, 2024
Company
Deals
Venus Medtech Partners with Valgen Holding on DragonFly Valve System
November 4, 2024
Company
Deals
Oculotronics Secures Pre-Series A Funding for Ophthalmic Surgical Robotics
November 4, 2024
Company
Drug
Sumitomo Pharma Receives Chinese Approval for Xenleta to Treat Pneumonia
November 4, 2024
Company
Drug
Gilead Announces Low-Carbon Bronchodilator Study for H1 2024
November 4, 2024
1
2
…
5
6
7
8
9
…
25
26
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?